The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages

  Hoftijzer, H C ^a   Heemstra, K A ^a   Visser, T J ^b   Le Cessie, S ^a   Peeters, R P ^b   Corssmit, E P M ^a   Smit, Johannes W A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IODOTHYRONINE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; THYROXINE DEIODINASE D1; THYROXINE DEIODINASE D2; THYROXINE DEIODINASE D3; UNCLASSIFIED DRUG;

ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; PRIORITY JOURNAL; SEX; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; ALLELES; CARCINOMA; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IODIDE PEROXIDASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN;

EID: 80052538824     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0235     Document Type: Article

References (29)

1. Dayan C.M., Panicker V. 2009 Novel insights into thyroid hormones from the study of common genetic variation. Nat Rev Endocrinol 5:211-218
2. Bianco A.C., Kim B.W. 2006 Deiodinases: Implications of the local control of thyroid hormone action. J Clin Invest 116:2571-2579 (Pubitemid 44511617)
3. Köhrle J. 1999 Local activation and inactivation of thyroid hormones: The deiodinase family. Mol Cell Endocrinol 151:103-119
4. Maeda A., Toyoda N., Yasuzawa-Amano S., Iwasaka T., Nishikawa M. 2003 Type 2 deiodinase expression is stimulated by growth factors in human vascular smooth muscle cells. Mol Cell Endocrinol 200:111-117 (Pubitemid 36331919)
5. Bianco A.C., Salvatore D., Gereben B., Berry M.J., Larsen P.R. 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89 (Pubitemid 34185306)
6. Boelen A., Wiersinga W.M., Fliers E. 2008 Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. Thyroid 18:123 129
7. Boelen A., Kwakkel J., Chassande O., Fliers E. 2009 Thyroid hormone receptor β mediates acute illness-induced alterations in central thyroid hormone metabolism. J Neuroendocrinol 21:465-472
8. Peeters R.P., Van den Beld A.W., Attalki H., Toor H., De Rijke Y.B., Kuiper G.G., Lamberts S.W., Janssen J.A., Uitterlinden A.G., Visser T.J. 2005 A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 289:E75-E81 (Pubitemid 40874937)
9. Canani L.H., Capp C., Dora J.M., Meyer E.L., Wagner M.S., Harney J.W., Larsen P.R., Gross J.L., Bianco A.C., Maia A.L. 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478 (Pubitemid 41014316)
10. Mentuccia D., Proietti-Pannunzi L., Tanner K., Bacci V., Pollin T.I., Poehlman E.T., Shuldiner A.R., Celi F.S. 2002 Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: Evidence of interaction with the Trp64Arg variant of the β3-adrenergic receptor. Diabetes 51:880-883 (Pubitemid 34760206)
11. Panicker V., Cluett C., Shields B., Murray A., Parnell K.S., Perry J.R., Weedon M.N., Singleton A., Hernandez D., Evans J., Durant C., Ferrucci L., Melzer D., Saravanan P., Visser T.J., Ceresini G., Hattersley A.T., Vaidya B., Dayan C.M., Frayling T.M. 2008 A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. J Clin Endocrinol Metab 93:3075-3081
12. De Jong F.J., Peeters R.P., Den Heijer T., Van der Deure W.M., Hofman A., Uitterlinden A.G., Visser T.J., Breteler M.M. 2007 The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92:636-640
13. Peeters R.P., Van Toor H., Klootwijk W., De Rijke Y.B., Kuiper G.G., Uitterlinden A.G., Visser T.J. 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888 (Pubitemid 36724470)
14. 4levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf) 68:175-181
15. Torlontano M., Durante C., Torrente I., Crocetti U., Augello G., Ronga G., Montesano T., Travascio L., Verrienti A., Bruno R., Santini S., D'Arcangelo P., Dallapiccola B., Filetti S., Trischitta V. 2008 Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab 93:910-913 (Pubitemid 351398572)
16. Heemstra K.A., Hoftijzer H.C., Van der Deure W.M., Peeters R.P., Fliers E., Appelhof B.C., Wiersinga W.M., Corssmit E.P., Visser T.J., Smit J.W. 2009 Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 71:279-283
17. Butler P.W., Smith S.M., Linderman J.D., Brychta R.J., Alberobello A.T., Dubaz O.M., Luzon J.A., Skarulis M.C., Cochran C.S., Wesley R.A., Pucino F., Celi F.S. 2010 The Thr92Ala 5′ type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: A pharmacogenomic study. Thyroid 20:1407-1412
18. Jostel A., Ryder W.D., Shalet S.M. 2009 The use of thyroid function tests in the diagnosis of hypopituitarism: Definition and evaluation of the TSH Index. Clin Endocrinol (Oxf) 71:529-534
19. Hansen P.S., Brix T.H., Sorensen T.I., Kyvik K.O., Hegedüs L. 2004 Major genetic influence on the regulation of the pituitary-thyroid axis: A study of healthy Danish twins. J Clin Endocrinol Metab 89:1181-1187 (Pubitemid 38368409)
20. Andersen S., Pedersen K.M., Bruun N.H., Laurberg P. 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072 (Pubitemid 36121067)
21. Benhadi N., Fliers E., Visser T.J., Reitsma J.B., Wiersinga W.M. 2010 Pilot study on the assessment of the setpoint of the hypothalamus-pituitary- thyroid axis in healthy volunteers. Eur J Endocrinol 162:323-329
22. Visser T.J., Docter R., Hennemann G. 1977 Radioimmunoassay of reverse tri-iodothyronine. J Endocrinol 73:395-396
23. Miller S.A., Dykes D.D., Polesky H.F. 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
24. Andersen S., Bruun N.H., Pedersen K.M., Laurberg P. 2003 Biologic variation is important for interpretation of thyroid function tests. Thyroid 13:1069-1078 (Pubitemid 37464559)
25. Maes M., Mommen K., Hendrickx D., Peeters D., D'Hondt P., Ranjan R., De M.F., Scharpe S. 1997 Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol (Oxf) 46:587-598 (Pubitemid 27286932)
26. Coppotelli G., Summers A., Chidakel A., Ross J.M., Celi F.S. 2006 Functional characterization of the 258 A/G (D2-ORFa-Gly3Asp) human type-2 deiodinase polymorphism: A naturally occurring variant increases the enzymatic activity by removing a putative repressor site in the 5′ UTR of the gene. Thyroid 16:625-632
27. Gereben B., Kollár A., Harney J.W., Larsen P.R. 2002 The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression. Mol Endocrinol 16:1667-1679 (Pubitemid 34743681)
28. Hovens G.C., Stokkel M.P., Kievit J., Corssmit E.P., Pereira A.M., Romijn J.A., Smit J.W. 2007 Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 92:2610-2615 (Pubitemid 47037365)
29. McGriff N.J., Csako G., Gourgiotis L., Lori C.G., Pucino F., Sarlis N.J. 2002 Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med 34:554-564 (Pubitemid 36113813)